Please assess the completion status of the following clinical trial:

Trial Title: DXR Stent(Previous Cilotax) Implantation Registry

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Patients with significant coronary artery disease and receiving Cilotax (dual drug eluting stent)~* The patient or guardian agrees to the study protocol and the schedule of clinical follow-up, and provides informed, written consent, as approved by the appropriate Institutional Review Board/Ethics Committee of the respective clinical site~Exclusion Criteria:~* Patients with a mixture of other DESs~* Terminal illness with life expectancy \<1 year~* Patients presented with cardiogenic shock

- Gender: ALL
- Minimum Age: 20 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).